Futibatinib,
TAS120,
TAS-120,
FGFR-IN-1,
UNII-4B93MGE4AL,
1448169-71-8,
4B93MGE4AL,
1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]prop-2-en-1-one,
TZ0,
futibatinib (proposed INN),
GTPL9786,
CHEMBL3701238,
SCHEMBL15345470,
TAS 120 [WHO-DD],
TAS 120,
BDBM161389,
BCP17213,
EX-A1862,
ZINC207800318,
CS-6031,
Example 2 [WO2013108809],
(S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one,
HY-100818,
US9108973, 2,
1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one,
2-Propen-1-one, 1-((3S)-3-(4-amino-3-(2-(3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-pyrrolidinyl)-,